Genetic LifeSpan Longevity and Biohacking Event Brings Biotechnology Innovation to Las Vegas

Alter New Media was on the ground at Genetic LifeSpan’s Premier Event in Las Vegas, bringing together entrepreneurs, medical professionals, innovators, investors and leaders working across longevity, biotechnology and personalized health.

LAS VEGAS, NV | September 29, 2026

Jeffrey Gaal Chief Revenue Officer (CRO) Genetic LifeSpan

There was a different kind of conversation taking place at The Stirling Club in Las Vegas this week.

From September 24 through September 26, Genetic LifeSpan brought together people working across longevity science, biohacking, biotechnology, precision health and entrepreneurship for its Premier Event. Alter New Media was there to experience the event firsthand and meet the people behind many of the ideas being discussed.

The event was co-hosted by Adam Vincent Gilmer, Founder and CEO of Genetic LifeSpan, whose work centers on precision wellness, longevity science, biological age analysis, genetics, and epigenetics. The Stirling Club described the gathering as three days of breakthrough technologies, expert insights, and networking among founders, clinicians, and operators in precision health.

The other event host was Andre Sappingfield, Chief Operating Officer, Genetic LifeSpan. His work centers on business operations, organizational growth, and scaling companies. Sappingfield brings approximately 20 years of experience across sales, technology, and operational initiatives, including experience helping businesses grow from startups to more than $100 million in revenue.

The program featured speakers including Bill Walsh and David Meltzer, alongside opportunities for startups and emerging companies to showcase their work, connect with investors, and build relationships across the growing longevity and health innovation ecosystem.

Bill Walsh, founder and CEO of Powerteam International, a business coaching and entrepreneurial education company. Walsh focuses on business growth, venture capital, marketing, leadership, and helping entrepreneurs develop and expand their companies.

David Meltzer, entrepreneur, investor, author, and co-founder of Sports 1 Marketing, formerly served as CEO of Leigh Steinberg Sports & Entertainment. He is also an executive producer of 2 Minute Drill, Office Hours, and Elevator Pitch, and hosts The Playbook podcast. His work focuses on entrepreneurship, business strategy, investment, leadership, and coaching. Their participation brought business development, company growth, and entrepreneurial experience into the event’s broader conversations about longevity, biotechnology, and emerging health technologies.

What stood out was the range of disciplines represented in the room, and the drive for preventative medicine and measures that anyone can take through testing, immune cell banking, stem cells, and nutraceuticals.

The event wasn’t simply a gathering about wellness products or longevity trends. The conversations extended into biotechnology, diagnostics, genetics, epigenetics, human performance, entrepreneurship, investment, and the business opportunities emerging around personalized health.

A Room Full of Perspective

One of the most interesting aspects of the event was the diversity of people contributing to the conversation.

Genetic LifeSpan’s programming brought together clinicians and medical professionals alongside entrepreneurs, investors, creators and companies developing products and technologies for the longevity market. The event also included opportunities for startups to pitch investors, companies to exhibit, and speakers to present their work.

Longevity is increasingly becoming an interdisciplinary industry. The people developing testing technologies are not necessarily the same people developing consumer products, medical applications, investment strategies or media platforms. Events that put those groups in the same room create opportunities for conversations that would not necessarily happen within a single industry.

From Genetics to the Bigger Longevity Conversation

Genetic LifeSpan itself operates across several areas of personalized health, including genetics, epigenetics, biological-age analysis, biomarker testing, precision nutraceuticals and immune-cell banking.

Its AgeCode™ platform is designed to combine genetic and epigenetic information into personalized reports, reflecting the company’s broader focus on helping individuals better understand biological factors associated with aging and health.

At the Las Vegas event, the conversation extended well beyond a single company or technology.

The broader question was how emerging science becomes something people can actually understand, use and build businesses around.

That is where the entrepreneurial component became particularly interesting.

MyHeartCode Brings Film Into the Conversation

Another project that demonstrated the intersection of science, storytelling and entrepreneurship was MyHeartCode™.

MyHeartCode director Henry Lipatov and producer Anna Oris at the Genetic LifeSpan Premier Event in Las Vegas, bringing together extensive experience in film, television, music and visual storytelling for a project at the intersection of cardiovascular science, longevity and innovation.

The project brought together producer Anna Oris, director Henry Lipatov, and Triple Board Certified Clinical and Academic Cardiologist Professor Dr. Dr. Ernst von Schwarz, connecting medical expertise with filmmaking and creative production.

Professor Dr. Dr. Ernst von Schwarz, Triple Board Certified Clinical and Academic Cardiologist, speaks during the Genetic LifeSpan Premier Event in Las Vegas, sharing his expertise in cardiovascular medicine, longevity and emerging health technologies.

Dr. von Schwarz brings a particularly substantial scientific background to the project: he is a triple board-certified clinical and academic cardiologist and clinical professor of medicine, with leadership experience at institutions including Cedars-Sinai, UCLA, and the Heart Institute of Southern California.

He has published more than 150 scientific papers in peer-reviewed medical journals, authored books and medical chapters, and has lectured internationally at major medical conferences including those of the American Heart Association, American College of Cardiology, and European Society of Cardiology. His career has also included extensive research in cardiovascular medicine, heart transplantation, cardiac devices, and stem-cell research.

Henry Lipatov, director of MyHeartCode, has directed more than 165 music videos and has worked with Jennifer Lopez, Eminem, Linkin Park, Chris Brown, Kelly Clarkson, 50 Cent, Fall Out Boy, Demi Lovato, OneRepublic and Why Don’t We. His career spans music videos, commercials, film and visual effects, with a portfolio that includes major international artists and large-scale productions.

Lipatov’s visual effects work has earned international recognition, including Best Visual Effects at the 2015 Cannes International Film Festival for A Tricky Treat. He has also worked as a director, producer, and visual-effects supervisor across film and television, bringing extensive experience in cinematic production and visual storytelling to MyHeartCode.

For Alter New Media, projects like MyHeartCode are particularly interesting because they demonstrate that innovation is not confined to laboratories, medical practices or technology companies.

Sometimes the challenge is communicating an emerging idea.

A film can create an entirely different entry point into a complex scientific conversation, allowing audiences to engage with an idea through story, imagery and human experience rather than technical information alone.

The Entrepreneurial Side of Longevity

The startup component of the Genetic LifeSpan event was another important part of the experience.

The event offered startup fast-pitch opportunities, with participating companies presenting to investor judges, as well as exhibitor and podcast opportunities.

That structure made the event relevant not only to people interested in longevity science, but also to founders thinking about commercialization.

There is a significant difference between having an interesting scientific concept and building a company around it.

Founders in this space have to think about research, product development, consumer education, regulation, positioning, partnerships, distribution and capital. Bringing those conversations together is part of what made the event particularly relevant from an entrepreneurial perspective.

Why This Conversation Matters for Las Vegas

Las Vegas is already a major destination for technology, entertainment, hospitality, sports and business events. The presence of a dedicated longevity and biohacking gathering adds another dimension to the city’s evolving entrepreneurial landscape.

The Stirling Club provided a setting where medical professionals could sit alongside founders, investors and innovators, creating a more intimate environment than a massive convention floor.

For a city increasingly associated with emerging industries and cross-sector business development, that type of gathering is worth watching.

What We Took Away From the Event

Alter New Media found that the most interesting takeaway was the people.

The medical professionals bringing clinical perspectives into the conversation, speakers enlightening the audience on the latest advancements in medtech, and the filmmakers and producers finding new ways to communicate complex ideas. The entrepreneurs building relationships across industries that traditionally operated separately.

That is where innovation becomes interesting. It’s about what one company is building, and what happens when different people with different related verticals of expertise get into the same room.

Genetic LifeSpan’s Las Vegas event offered exactly that kind of environment.

For an emerging industry still defining what longevity, precision health, and human performance will look like in the years ahead, there is clearly much more to the conversation.

Alter New Media covers the people, companies and ideas shaping business, technology, entrepreneurship and the future of innovation.